Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19
Clinical trial NCT04486313 · COMPLETED
Trial details
- NCT number
- NCT04486313
- Sponsor
- Romark Laboratories L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2021-02-08
- Enrollment
- 935
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.